K. Hale, P. Shaw, L. Dalla-pozza, C. Macintyre, D. Isaacs et al., Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant, British Journal of Haematology, vol.117, issue.2, pp.263-72, 2010.
DOI : 10.1099/0022-1317-51-7-601

C. Clancy and M. Nguyen, Finding the ???Missing 50%??? of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care, Clinical Infectious Diseases, vol.56, issue.9, pp.1284-92, 2013.
DOI : 10.1093/cid/cit006

O. Marchetti, F. Lamoth, M. Mikulska, C. Viscoli, P. Verweij et al., ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients, Bone Marrow Transplantation, vol.48, issue.6, pp.846-54, 2012.
DOI : 10.1128/JCM.01466-10

D. Karageorgopoulos, E. Vouloumanou, F. Ntziora, A. Michalopoulos, P. Rafailidis et al., ??-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis, Clinical Infectious Diseases, vol.52, issue.6, pp.750-70, 2011.
DOI : 10.1093/cid/ciq206

F. Reischies, J. Prattes, A. Woelfler, S. Eigl, and M. Hoenigl, Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation, Transplant Infectious Disease, vol.46, issue.4, pp.466-70, 2016.
DOI : 10.1016/j.ijantimicag.2015.05.017

E. Levesque, E. Anbassi, S. Sitterle, E. Foulet, F. Merle et al., Contribution of (1,3)-Beta-d-Glucan to Diagnosis of Invasive Candidiasis after Liver Transplantation, Journal of Clinical Microbiology, vol.53, issue.3, pp.771-777, 2015.
DOI : 10.1128/JCM.03018-14

B. Posteraro, D. Pascale, G. Tumbarello, M. Torelli, R. Pennisi et al., Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1???3)-??-D-glucan assay, Candida score, and colonization index, Critical Care, vol.15, issue.5, p.249, 2011.
DOI : 10.1007/s10096-004-1104-x

D. Pauw, B. Walsh, T. Donnelly, J. Stevens, D. Edwards et al., Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, pp.1813-1834, 2008.
DOI : 10.1086/588660

M. Ceesay, S. Desai, L. Berry, J. Cleverley, C. Kibbler et al., -glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients, British Journal of Haematology, vol.116, issue.Suppl. 1, pp.219-248, 2015.
DOI : 10.1182/blood-2010-02-268151

H. Hammarstrom, N. Kondori, V. Friman, and C. Wenneras, How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors, European Journal of Clinical Microbiology & Infectious Diseases, vol.51, issue.1, pp.917-942, 2015.
DOI : 10.1128/JCM.02356-12

F. Lamoth, M. Cruciani, C. Mengoli, E. Castagnola, O. Lortholary et al., ??-Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3), Third European Conference on Infections in Leukemia (ECIL-3), pp.633-676, 2012.
DOI : 10.1093/cid/cir897

A. Groll, E. Castagnola, S. Cesaro, J. Dalle, D. Engelhard et al., Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation, The Lancet Oncology, vol.15, issue.8, pp.327-367, 2014.
DOI : 10.1016/S1470-2045(14)70017-8

M. Louis, J. Guitard, M. Jodar, T. Ancelle, D. Magne et al., Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii, Journal of Clinical Microbiology, vol.53, issue.12, pp.3870-3875, 2015.
DOI : 10.1128/JCM.02072-15

G. Martin, D. Mannino, S. Eaton, and M. Moss, The Epidemiology of Sepsis in the United States from 1979 through 2000, New England Journal of Medicine, vol.348, issue.16, pp.1546-54, 1979.
DOI : 10.1056/NEJMoa022139

W. Trick, S. Fridkin, J. Edwards, R. Hajjeh, and R. Gaynes, Secular Trend of Hospital???Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989???1999, Clinical Infectious Diseases, vol.35, issue.5, pp.627-657, 2002.
DOI : 10.1086/342300

J. Auberger, C. Lass-florl, M. Aigner, J. Clausen, G. Gastl et al., Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study, Journal of Antimicrobial Chemotherapy, vol.67, issue.9, pp.2268-73, 2012.
DOI : 10.1093/jac/dks189

R. Herbrecht, V. Letscher-bru, C. Oprea, B. Lioure, J. Waller et al., Galactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients, Journal of Clinical Oncology, vol.20, issue.7, pp.1898-906, 2002.
DOI : 10.1200/JCO.2002.07.004

S. Choi, E. Kang, H. Eo, S. Yoo, J. Kim et al., galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients, Pediatric Blood & Cancer, vol.32, issue.2, pp.316-338, 2013.
DOI : 10.1016/S0924-8579(08)70012-8

M. Leeflang, Y. Debets-ossenkopp, C. Visser, R. Scholten, L. Hooft et al., Galactomannan detection for invasive aspergillosis in immunocompromized patients, Cochrane Database Syst Rev, vol.5, issue.1, p.7394, 2008.
DOI : 10.1186/1471-2288-5-19

P. Badiee, A. Alborzi, M. Karimi, B. Pourabbas, P. Haddadi et al., Diagnostic potential of nested PCR, galactomannan EIA, and Beta-D-glucan for invasive aspergillosis in pediatric patients, The Journal of Infection in Developing Countries, vol.6, issue.04, pp.352-359, 2012.
DOI : 10.3855/jidc.2110

M. Abe, M. Kimura, H. Araoka, S. Taniguchi, and A. Yoneyama, Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia, Medical Mycology, vol.52, issue.8, pp.835-875, 2014.
DOI : 10.1093/mmy/myu066

K. Marr, S. Balajee, L. Mclaughlin, M. Tabouret, C. Bentsen et al., Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance, The Journal of Infectious Diseases, vol.190, issue.3, pp.641-650, 2004.
DOI : 10.1086/422009

T. Obayashi, K. Negishi, T. Suzuki, and N. Funata, ???Glucan Assay for the Diagnosis of Invasive Fungal Infections???A Study Based on Autopsy Cases from 6 Years, Clinical Infectious Diseases, vol.46, issue.12, pp.1864-70, 2008.
DOI : 10.1086/588295

E. Azoulay, N. Guigue, M. Darmon, D. Mokart, V. Lemiale et al., 3)-Beta-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hemato- logical malignancies, Oncotarget, vol.1, 2016.

S. Jaijakul, J. Vazquez, R. Swanson, and L. Ostrosky-zeichner, (1,3)-??-D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis, Clinical Infectious Diseases, vol.55, issue.4, pp.521-527, 2012.
DOI : 10.1093/cid/cis456

L. Senn, J. Robinson, S. Schmidt, M. Knaup, N. Asahi et al., ,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia, Clin Infect Dis, vol.146, issue.6, pp.878-85, 2008.

C. Sims, S. Jaijakul, J. Mohr, J. Rodriguez, M. Finkelman et al., Correlation of Clinical Outcomes with ??-Glucan Levels in Patients with Invasive Candidiasis, Journal of Clinical Microbiology, vol.50, issue.6, pp.2104-2110, 2012.
DOI : 10.1128/JCM.00773-12

A. Koltze, P. Rath, S. Schoning, J. Steinmann, T. Wichelhaus et al., ??-d-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation, Journal of Clinical Microbiology, vol.53, issue.8, pp.2605-2615, 2015.
DOI : 10.1128/JCM.00747-15

P. Pini, C. Bettua, C. Orsi, C. Venturelli, F. Forghieri et al., Evaluation of serum (1???????3)-??-d-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors, Infection, vol.42, issue.2, pp.223-256, 2016.
DOI : 10.1007/s15010-013-0558-0

M. Ellis, B. Al-ramadi, M. Finkelman, U. Hedstrom, J. Kristensen et al., Assessment of the clinical utility of serial ??-D-glucan concentrations in patients with persistent neutropenic fever, Journal of Medical Microbiology, vol.57, issue.3, pp.287-95, 2008.
DOI : 10.1099/jmm.0.47479-0

N. Maharshak, E. Huh, C. Paiboonrungruang, M. Shanahan, L. Thurlow et al., Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2, Infection and Immunity, vol.83, issue.7, pp.2762-70, 2015.
DOI : 10.1128/IAI.00425-15
URL : http://iai.asm.org/content/83/7/2762.full.pdf

M. Siemann, M. Koch-dorfler, and M. Gaude, sandwich enzyme-linked immunosorbent assay, Mycoses, vol.35, issue.9-10, pp.373-380, 1998.
DOI : 10.1111/j.1439-0507.1998.tb00356.x